Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

By Jennifer Rigby and Michael Erman LONDON (Reuters) - Pfizer (NYSE:PFE) has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the worlds… [+2955 chars]

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO
Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Breakthrough: Will DCGI-approved Entod Pharma's PresVu eyedrops eliminate need for reading glasses?
Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR)

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
The Peanut Allergy Vaccine